High priorities: sustainability & continual improvement LEARN MORE>
High priorities: sustainability & continual improvement
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013 LEARN MORE>
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013
>Go!

Quality

Actavis is committed to being a global leader in improving the health and quality of people’s lives worldwide. We focus on the development, manufacture and sale of quality generic, specialty branded pharmaceuticals, biologics and medical devices around the world.

Actavis is committed to adherence to all applicable regulatory requirements and the highest industry standards. We are committed to maintaining quality by all employees at all levels throughout our enterprise.

Actavis ensures compliance by continuous assessment and monitoring of the output of the existing quality systems, and application of evolving industry guidelines and regulations.

Quality is the responsibility of every Actavis team member. It is achieved by teamwork and commitment. The name Actavis represents the standard of quality to our employees, our customers and the communities in which we work.

Good Manufacturing Practice

Good Manufacturing Practice (GMP) is a regulatory guideline imposed on all manufacturers of pharmaceuticals to ensure that finished products have the identity, strength, quality and purity they are required to have.

GMP describes the methods, the controls, the equipment and facilities that must be put into place for the manufacturing of pharmaceutical products. Actavis’ ongoing auditing program verifies continuous adherence to GMP standards, appropriate training of employees and that resources are being utilized as efficiently as possible.